Focal Medical

About:

A biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system.

Website: https://focalmedical.co

Twitter/X: FocalMedical

Top Investors: Khosla Ventures, Piedmont Capital Partners, Spectrum Financial

Description:

Focal Medical, Inc. is a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system. The Company’s lead product is a targeted therapeutic product delivering gemcitabine (an FDA approved chemotherapeutic) actively and directly to the pancreas by non-circulatory pathways to treat pancreatic cancer. Focal Medical, Inc. is formerly known as Advanced Chemotherapy Technologies, Inc. It is headquartered in Cary, North Carolina.

Total Funding Amount:

$12.5M

Headquarters Location:

Cary, North Carolina, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)focalmedical.co

Founders:

Jen Jen Yeh, Joseph M. DeSimone

Number of Employees:

11-50

Last Funding Date:

2020-09-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai